Fibrotic diseases such as non-alcoholic steatohepatitis (NASH) – caused by inflammation of the liver by a buildup of fat – currently have no non-invasive methods to monitor treatment response. In order to address this, Glympse Bio has developed activity-based biosensors, designed to detect early signs of disease, predict stage of disease and support the development […]

Affinity Empowering  Chief Behavioral Health Officer and Chief Operating Officer Dr. Michael Tkach studies the linkage between inflammation and depression while pioneering a streamlined and powerful approach to pool testing. Two swabs anyone?

Three months after health officials announced Canada’s first known case of rare, post-vaccination blood clots, an international team of researchers at McMaster University is developing a “highly effective” treatment for people with, or at risk of, blood clots. Prof. Jeffrey Weitz says data from a study, published in late July, showed that a single post-operative dose of abelacimab reduced the […]